Event / Health

Medical Device Injury Litigation France

← All events

Updated

French actor Arnaud Denis underwent euthanasia following severe complications from a polypropylene hernial mesh implant. Denis experienced immune dysfunction, neurological symptoms, and sensory loss after implantation in 2023. His legal complaints were dismissed in August 2026, but a new complaint with civil party constitution was filed September 18, 2026. The French medical safety agency documented 75 adverse effect reports from mesh implants in early 2025, with Denis helping document hundreds of similar cases.

3 reported locations
Geography of the reported facts
  1. Paris, France
  2. Namur, Namur, Belgium
  3. France

The story so far

Daily activity

3 articles
0 articles

2026-09-22 to 2026-11-03 · UTC publication dates

Coverage begins 22 Sept, 14:58 UTC

Follow the documented timeline or explore the related reporting.

What happened

The facts
  1. French actor files complaint for involuntary injury over mesh implant

    Arnaud Denis filed a complaint against unknown persons on January 5, 2026, for involuntary injury related to the hernial mesh implant. The complaint was dismissed without prosecution on August 31, 2026, with prosecutors citing insufficiently characterized offense due to lack of scientifically established causal link required by penal law. Denis's attorney subsequently filed a new complaint on September 18, 2026, with civil party constitution to obtain opening of a judicial investigation.

    1 corroborating report

  2. French actor Arnaud Denis undergoes euthanasia in Belgium at age 43

    French actor and theater director Arnaud Denis, aged 43, underwent euthanasia in Belgium on September 22, 2026. The procedure was conducted with consultation from three physicians in Namur, Belgium. Denis had been in a state of severe disability and experiencing intense pain for several months, leading to his decision to pursue euthanasia as a final option to end his suffering.

    1 corroborating report

  3. French actor suffered severe complications from hernial mesh implant

    Arnaud Denis underwent hernia surgery on July 17, 2023, during which a polypropylene mesh implant was placed. Following the implant, Denis experienced multiple severe complications including abnormal pain, loss of hearing, vision problems, loss of appetite, blackening of testicle tissue, blood in urine and stools, and other symptoms. These complications persisted even after the implant was removed in the United States in April 2024, ultimately forcing Denis to abandon his acting career and leave him in severe disability.

    1 corroborating report

  4. Actor creates support collective for victims of hernial mesh implants

    Arnaud Denis created a collective called 'Victims of French Hernial Mesh Prostheses' that assembles hundreds of testimonies on social media from people experiencing adverse effects from hernial mesh implants. The collective serves as a platform for individuals to share their concerns and experiences with these medical devices.

    1 corroborating report

  5. Denis diagnosed with encephalomyelitis and ASIA syndrome related to mesh implant

    Medical expertise determined that Arnaud Denis had encephalomyelitis myalgic in the context of ASIA syndrome (autoimmune/autoinflammatory syndrome induced by adjuvants). The hernial mesh implant was believed to have triggered persistent inflammation, resulting in immune system dysfunction. ASIA syndrome is a medical condition involving symptoms such as intense fatigue, diffuse pain, cognitive and neurological disorders, and potential triggering or exacerbation of autoimmune diseases.

    1 corroborating report

  6. French medical safety agency receives 75 reports of adverse effects from hernial mesh implants

    Between January 1, 2025 and May 31, 2025, the French National Agency for Medicines and Health Products Safety (ANSM) received 75 reports of adverse effects related to hernial mesh implants. This indicates a pattern of complications associated with these medical devices.

    1 corroborating report

Read the coverage